Abstract
Background: Based on the biological significance of hederagenin-type saponins found in our previous investigation, a series of new hederagenin derivatives were designed and synthesized.
Methods: Their in vitro antiproliferative activities were evaluated against the HepG2 liver cancer cell line and normal cell line L929 by MTT assay.
Results: The preliminary bioassay results demonstrated that all the tested compounds 1-7 showed potent anti-hepatoma activities, and some compounds exhibited better effects than 5-fluorouracil against human hepatocellular carcinoma HepG2 cell line. Furthermore, compound 5 showed a significant antihepatoma activity against HepG2 cells with an IC50 value of 1.88 µM. Besides, all of the tested compounds showed a low cytotoxic effect against the normal cell line L929.
Conclusion: All the compounds 1-7 displayed superior selectivity against human hepatocellular carcinoma HepG2 cell line, and the results suggest that the structural modifications of C ring on the hederagenin backbone are vital for modulating anti-hepatoma activities.
Keywords: Nigella glandulifera, hederagenin-type saponin, hederagenin, structural modification, anti-hepatoma, cytotoxicity.
[http://dx.doi.org/10.1021/la4049902] [PMID: 24690040]
[http://dx.doi.org/10.1248/bpb.25.472] [PMID: 11995927]
[http://dx.doi.org/10.3109/13880209.2014.922586] [PMID: 25471378]
[http://dx.doi.org/10.1055/s-0032-1315040] [PMID: 22814889]
[http://dx.doi.org/10.1186/1472-6882-14-412] [PMID: 25342273]
[http://dx.doi.org/10.1016/j.indcrop.2018.08.073]
[PMID: 27429843]
[http://dx.doi.org/10.1016/j.fitote.2018.08.004] [PMID: 30114469]
[http://dx.doi.org/10.1016/j.ejmech.2018.02.073] [PMID: 29499490]
[http://dx.doi.org/10.13005/ojc/310341]
[http://dx.doi.org/10.1016/j.fct.2009.04.034] [PMID: 19406196]
[http://dx.doi.org/10.1021/acs.jnatprod.7b00578] [PMID: 29131631]
[http://dx.doi.org/10.3390/11090693] [PMID: 17971743]
[http://dx.doi.org/10.1007/BF02980076] [PMID: 15180300]
[http://dx.doi.org/10.1248/cpb.39.116]
[http://dx.doi.org/10.1016/j.bmcl.2012.08.064] [PMID: 23466224]
[PMID: 22312713]
[http://dx.doi.org/10.1016/j.fitote.2012.03.003] [PMID: 22433396]
[http://dx.doi.org/10.1002/cbdv.201200087] [PMID: 23576356]
[http://dx.doi.org/10.1016/j.bmcl.2017.06.048] [PMID: 28666736]